Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;64(6):1369-1387.
doi: 10.1016/j.pcl.2017.08.005.

New Antimicrobial Agents for the Treatment of Staphylococcal Infections in Children

Roopali Sharma  1 , Densley Francois  2 , Margaret R Hammerschlag  3
Affiliations
Review

New Antimicrobial Agents for the Treatment of Staphylococcal Infections in Children

Roopali Sharma et al. Pediatr Clin North Am. 2017 Dec.

Abstract

Several new antimicrobial agents-daptomycin, ceftaroline, telavancin, dalbavancin, and-tedizolid have been approved for the treatment of staphylococcal infections, including methicillin-resistant Staphylococcus aureus (MRSA), in adults. Ceftaroline and daptomycin have been approved by the US Food and Drug Administration for use in children. Ceftaroline, a beta-lactam antibiotic with activity against MRSA, has been approved for treatment of community-acquired bacterial pneumonia and complicated skin and skin structure infections. Daptomycin has been approved for treatment of complicated skin and skin structure infections. In this article, we review the pharmacokinetics and pharmacodynamics of these antibiotics and available data on use in children.

Keywords: Ceftaroline; Dalbavancin; Daptomycin; MRSA; Staphylococcus aureus; Tedizolid; Telavancin; Vancomycin.

PubMed Disclaimer

MeSH terms

Substances